Search
for
Sort by
Research 721–750 of 1000+
- Urological Oncology: Prostate Cancer
- Editorial Comment
- Slow progress in prostate cancer
- Medikamentöse Therapie des benignen Prostatasyndroms (BPS)
- Market Analysis of 5α-Reductase Inhibitor
- Why would men use finasteride in 2005?
- Successes and failures of evidence based urology
- Reply by the authors
- A4. Hair loss – surgical and pharmacological treatment
- Men??s Health
- Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor
- Treatment of Frontal Fibrosing Alopecia
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Antiandrogens
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- 10 Medical therapyMedical Treatment of Male and Female Pattern Hair Loss
- A systematic review on the treatment of androgenetic alopecia
- The challenging role of antiandrogens in the management of polycystic ovary syndrome
- Faculty Opinions recommendation of Post-finasteride syndrome: a surmountable challenge for clinicians.
- A preliminary result of adipose derived stem cell treatment for female pattern hair loss
- Update Treatment of Male Androgenetic Alopecia
- Management of androgenetic alopecia: a review
- Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
- Post-finasteride syndrome: our current knowledge
- The role of mutations on gene AR, in androgenetic alopecia syndrome
- Analysis of Female Pattern Hair loss
- New Perspectives on the Treatment of Androgenetic Alopecia
- Response to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategies
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies